Europe Generic Injectables Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Generic Injectables Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Generic Injectables Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Generic Injectables Market Regional Analysis

6.2 Europe Generic Injectables Market Revenue 2019-2028 (US$ Million)

6.3 Europe Generic Injectables Market Forecast Analysis

7. Europe Generic Injectables Market Analysis – by Product Type

7.1 Large Molecule Injectables

7.1.1 Overview
7.1.2 Large Molecule Injectables: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Small Molecule Injectables

7.2.1 Overview
7.2.2 Small Molecule Injectables: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Generic Injectables Market Analysis – by Container Type

8.1 Vials

8.1.1 Overview
8.1.2 Vials: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Premix

8.2.1 Overview
8.2.2 Premix: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Prefilled Syringes

8.3.1 Overview
8.3.2 Prefilled Syringes: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Ampoules

8.4.1 Overview
8.4.2 Ampoules: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Generic Injectables Market Analysis – by Application

9.1 Oncology

9.1.1 Overview
9.1.2 Oncology: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Infectious Diseases

9.2.1 Overview
9.2.2 Infectious Diseases: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Cardiology

9.3.1 Overview
9.3.2 Cardiology: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Diabetes

9.4.1 Overview
9.4.2 Diabetes: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.5 Immunology

9.5.1 Overview
9.5.2 Immunology: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Generic Injectables Market Analysis – by Route of Administration

10.1 Intravenous

10.1.1 Overview
10.1.2 Intravenous: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Intramuscular

10.2.1 Overview
10.2.2 Intramuscular: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Subcutaneous

10.3.1 Overview
10.3.2 Subcutaneous: Europe Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. Europe Generic Injectables Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Generic Injectables Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 Europe Generic Injectables Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 UK: Europe Generic Injectables Market Breakdown, by Product Type
11.2.1.1.2 UK: Europe Generic Injectables Market Breakdown, by Container Type
11.2.1.1.3 UK: Europe Generic Injectables Market Breakdown, by Application
11.2.1.1.4 UK: Europe Generic Injectables Market Breakdown, by Route of Administration

11.2.1.2 Germany: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Germany: Europe Generic Injectables Market Breakdown, by Product Type
11.2.1.2.2 Germany: Europe Generic Injectables Market Breakdown, by Container Type
11.2.1.2.3 Germany: Europe Generic Injectables Market Breakdown, by Application
11.2.1.2.4 Germany: Europe Generic Injectables Market Breakdown, by Route of Administration

11.2.1.3 France: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 France: Europe Generic Injectables Market Breakdown, by Product Type
11.2.1.3.2 France: Europe Generic Injectables Market Breakdown, by Container Type
11.2.1.3.3 France: Europe Generic Injectables Market Breakdown, by Application
11.2.1.3.4 France: Europe Generic Injectables Market Breakdown, by Route of Administration

11.2.1.4 Russia: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Russia: Europe Generic Injectables Market Breakdown, by Product Type
11.2.1.4.2 Russia: Europe Generic Injectables Market Breakdown, by Container Type
11.2.1.4.3 Russia: Europe Generic Injectables Market Breakdown, by Application
11.2.1.4.4 Russia: Europe Generic Injectables Market Breakdown, by Route of Administration

11.2.1.5 Italy: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Italy: Europe Generic Injectables Market Breakdown, by Product Type
11.2.1.5.2 Italy: Europe Generic Injectables Market Breakdown, by Container Type
11.2.1.5.3 Italy: Europe Generic Injectables Market Breakdown, by Application
11.2.1.5.4 Italy: Europe Generic Injectables Market Breakdown, by Route of Administration

11.2.1.6 Rest of Europe: Europe Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Generic Injectables Market Breakdown, by Product Type
11.2.1.6.2 Rest of Europe: Europe Generic Injectables Market Breakdown, by Container Type
11.2.1.6.3 Rest of Europe: Europe Generic Injectables Market Breakdown, by Application
11.2.1.6.4 Rest of Europe: Europe Generic Injectables Market Breakdown, by Route of Administration

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 AstraZeneca

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Baxter International Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Biocon

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Fresenius SE & Co. KGaA

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 GlaxoSmithKline plc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Hikma Pharmaceuticals PLC

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Johnson and Johnson Services, Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Lupin

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Merck & Co., Inc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Pfizer Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Viatris Inc

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Generic Injectables Market